Drug-Induced Interstitial Lung Disease after Anthracycline-Combined Chemotherapy for Breast Cancer: A Case Report and Literature Review
Drug-induced interstitial lung disease (DILD) has been occasionally reported with various causative drugs. In the context of breast cancer, anthracycline infrequently causes pulmonary adverse events. We report a 67-year-old woman with cT2N0M0 triple-negative breast cancer who received neoadjuvant ch...
Guardado en:
Autores principales: | Hideko Hoshina, Hiroyuki Takei |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Karger Publishers
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b7db9562aaf4b3c85a16ae8741a0fcc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Skin Rash and Interstitial Pneumonia Can Be a Fatal Combination: A Rare Case of Anti-Melanoma Differentiation-Associated Gene 5 (MDA5)-Associated Interstitial Lung Disease
por: Giorgia Borio, et al.
Publicado: (2021) -
Clopidogrel-Induced Interstitial Lung Disease: A Case Report
por: An J, et al.
Publicado: (2021) -
Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Amigues I, et al.
Publicado: (2019) -
Clinical Case of Idiopathic Interstitial Pneumonia: Expert Approaches
por: V. M. Karetnikova, et al.
Publicado: (2019) -
Interstitial lung abnormalities – current knowledge and future directions
por: Gisli Thor Axelsson, et al.
Publicado: (2021)